Dr John Robson
Senior Clinical Lecturer
email: j.robson@qmul.ac.uk
Phone: +44 20 7882 2491
Fax: +44 20 7882 2533
Centre for Primary Care and Public Health
Barts and The London School of Medicine and Dentistry
Postal address:
2 Newark Street
Whitechapel
London
E1 2AT
John Robson is a general practitioner in Tower Hamlets and senior lecturer at QMUL. He has a particular interest in cardiovascular disease and in the equitable delivery of primary care clinical services. Since 1989 he has been the lead for the Clinical Effectiveness Group at QMUL.
In 2007/8 he Chaired NICE cardiovascular risk estimation and lipid modification guidelines which established CVD risk estimation now included in the national NHS Health Check. He is a co-author of QRisk: www.qrisk.org and diabetes risk www.qdscore.org. With colleagues in CEG, recording of self-reported ethnicity has been pioneered in East London and a clinical database o firmly established with local GPs using EMIS Web accessing 800,000 patient records. He is PI on a Health Foundation grant to develop profiles of equity at PCT and practice level.
Publications:
2007 Jul 21
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Hippisley-Cox J;Coupland C;Vinogradova Y;Robson J;May M;Brindle P;, BMJ, vol: 335, pp:136-
2007
The performance of the QRISK cardiovascular risk prediction algorithm in an external UK sample of patients from general practice: a validation study
Hippisley-Cox J;Coupland C;Vinogradova Y;Robson J;Brindle P;, Heart, vol: 12, pp:-
2006
Cardiovascular disease updated guidelines - Clinical Effectiveness Group
Robson J;George B;d'Ancona G;
2004
Cardiovascular risk assessment.
Robson J;, BMJ Learning, vol: , pp:-
2003 Jun 28
Comparison of methods to identify individuals at increased risk of coronary disease from the general population
Wilson S;Johnston A;Robson J;Poulter N;Collier D;Feder G;Caulfield MJ;, BMJ, vol: 326, pp:1436-
2003 Apr
Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?
Wilson S;Johnston A;Robson J;Poulter NR;Collier DJ;Feder GS;Caulfield MJ;
2003
What happened to evident in NICE guidance on heart failure
Robson J;, BMJ, vol: 327, pp:-